Antiphospholipid antibodies: neuropsychiatric presentations

Area of Science:

• Neurology
• Psychiatry
• Immunology

Background:

• Antiphospholipid antibodies (aPL) are implicated in a spectrum of neurological, psychological, and psychiatric conditions.
• While thrombotic events define the antiphospholipid syndrome's neurological impact, other associations remain poorly understood.
• Existing evidence suggests a potential psychiatric role for aPL, but requires further investigation.

Purpose of the Study:

• To explore the association between antiphospholipid antibodies and neurological, psychological, and psychiatric manifestations.
• To investigate the underlying pathophysiological mechanisms linking aPL to non-thrombotic clinical presentations.
• To clarify the extent and nature of the psychiatric impact of aPL.

Main Methods:

• Review of existing literature on aPL and associated neurological/psychiatric conditions.
• Analysis of clinical data linking aPL to diverse manifestations.
• Exploration of proposed cellular and molecular pathways.

Main Results:

• aPL are associated with a broad range of neurological and psychiatric symptoms beyond established thrombotic events.
• The strength of these associations varies, and underlying mechanisms are not fully elucidated.
• Preliminary data suggest a significant psychiatric impact of aPL.

Conclusions:

• Antiphospholipid antibodies present a complex clinical picture extending to psychiatric disorders.
• Further research is crucial to elucidate the magnitude and cellular/molecular mechanisms of aPL's psychiatric impact.
• Understanding these links is vital for comprehensive patient management in antiphospholipid syndrome.